Ask AI
Public Law117th CongressHealth
H.R. 941Became Law

TRANSPLANT Act of 2021

This bill became law

Filed
Comm.
Floor
Both
Law

What it doesSummary public law (May 26, 2021)

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.

What just happenedMay 26, 2021

Became Public Law No: 117-15.

Who’s behind it

Rep. Matsui, Doris O. [D-CA-6](D-CA)Sponsor
23 cosponsors17 D6 R
Read on Congress.gov
23cosponsors2committees24actions1related bills9subjects
  1. May 26, 2021President

    Became Public Law No: 117-15.

  2. May 26, 2021BecameLaw36000

    Became Public Law No: 117-15.

  3. May 26, 2021President

    Signed by President.

  4. May 26, 2021BecameLaw36000

    Signed by President.

  5. May 20, 2021Floor

    Presented to President.

  6. May 20, 2021President28000

    Presented to President.

  7. May 18, 2021Floor

    Message on Senate action sent to the House.

  8. May 17, 2021Floor

    Passed Senate without amendment by Voice Vote.

  9. May 17, 2021Floor17000

    Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.

  10. May 17, 2021Discharge

    Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S2550)

    Health, Education, Labor, and Pensions Committee
  11. May 17, 2021Committee14500

    Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S2550)

    Health, Education, Labor, and Pensions Committee
  12. Apr 19, 2021IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  13. Apr 15, 2021FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  14. Apr 15, 2021FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109). (text: 04/14/2021 CR H1752-1753)

  15. Apr 15, 2021Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109).(text: 04/14/2021 CR H1752-1753)

  16. Apr 15, 2021FloorH30000

    Considered as unfinished business. (consideration: CR H1829)

  17. Apr 14, 2021FloorH37220

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

  18. Apr 14, 2021FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 941.

  19. Apr 14, 2021FloorH30000

    Considered under suspension of the rules. (consideration: CR H1752-1754)

  20. Apr 14, 2021FloorH30300

    Mr. Pallone moved to suspend the rules and pass the bill.

  21. Feb 9, 2021Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  22. Feb 8, 2021IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  23. Feb 8, 2021IntroReferralIntro-H

    Introduced in House

  24. Feb 8, 2021IntroReferral1000

    Introduced in House

Public LawMay 26, 202149

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.

Passed SenateMay 17, 202155

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.

Passed HouseApr 15, 202153

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.

Introduced in HouseFeb 8, 2021

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.

TRANSPLANT Act of 2021 — Informed